439
70. Lecaroz MC, Blanco-Prieto MJ, Campanero MA, Salman H, Gamazo C. Poly (D, L-lactidecoglycolide) particles containing gentamicin: pharmacokinetics and pharmacodynamics in
Brucella melitensis-infected mice. Antimicrob Agents Chemother. 2007;51(4):1185–90.
71. Errico C, Bartoli C, Chiellini F, Chiellini E. Poly (hydroxyalkanoates)-based polymeric
nanoparticles for drug delivery. Biomed Res Int. 2009;2009:571702.
72. Park J, Fong PM, Lu J, Russell KS, Booth CJ, Saltzman WM, et al. PEGylated PLGA
nanoparticles for the improved delivery of doxorubicin. Nanomedicine. 2009;5(4):410–8.
73. Shah N, Chaudhari K, Dantuluri P, Murthy R, Das S. Paclitaxel-loaded PLGA nanoparticles
surface modified with transferrin and Pluronic® P85, an in vitro cell line and in vivo biodistribution studies on rat model. J Drug Target. 2009;17(7):533–42.
74. Yang H, Li K, Liu Y, Liu Z, Miyoshi H. Poly (D, L-lactide-co-glycolide) nanoparticles encapsulated fluorescent isothiocyanate and paclitaxol: preparation, release kinetics and anticancer
effect. J Nanosci Nanotechnol. 2009;9(1):282–7.
75. Kim T-H, Jeong Y-I, Jin S-G, Pei J, Jung T-Y, Moon K-S, et al. Preparation of polylactideco- glycolide nanoparticles incorporating celecoxib and their antitumor activity against brain
tumor cells. Int J Nanomedicine. 2011;6:2621–31.
76. Sundar S, Kundu J, Kundu SC. Biopolymeric nanoparticles. Sci Technol Adv Mater.
2010;11(1):014104.
77. de Assis DN, Mosqueira VCF, Vilela JMC, Andrade MS, Cardoso VN. Release profiles and
morphological characterization by atomic force microscopy and photon correlation spectroscopy of 99m technetium-fluconazole nanocapsules. Int J Pharm. 2008;349(1):152–60.
78. Shi HG, Farber L, Michaels JN, Dickey A, Thompson KC, Shelukar SD, et al. Characterization
of crystalline drug nanoparticles using atomic force microscopy and complementary techniques. Pharm Res. 2003;20(3):479–84.
79. Gupta H, Aqil M, Khar RK, Ali A, Bhatnagar A, Mittal G. Sparfloxacin-loaded PLGA
nanoparticles for sustained ocular drug delivery. Nanomedicine. 2010;6(2):324–33.
80. Zhao H, Lin ZY, Yildirimer L, Dhinakar A, Zhao X, Wu J. Polymer-based nanoparticles for
protein delivery: design, strategies and applications. J Mater Chem B. 2016;4(23):4060–71.
81. Naghsh N, Mashayekh AM, Khodadadi S. Effects of silver nanoparticle on lactate dehydrogenase activity and histological changes of heart tissue in male wistar rats. J Fasa Univ Med
Sci. 2013;2(4):303–7.
82. Razavian M, Safarpour E, Roshanai K, Yazdian M, Heidarieh N. Study of some biochemical
and hematological parameters changes of wistar rats blood parallel to oral nanosilver consumption. J Babol Univ Med Sci. 2011;13(1):22–7.
83. Alkaladi A, Abdelazim A, Afifi M. Antidiabetic activity of zinc oxide and silver nanoparticles
on streptozotocin-induced diabetic rats. Int J Mol Sci. 2014;15(2):2015–23.
84. Mousavi Z, Hassanpourezatti M, Najafizadeh P, Rezagholian S, Rhamanifar MS, Nosrati
N. Effects of subcutaneous injection MnO2 micro-and nanoparticles on blood glucose level
and lipid profile in rat. Iranian J Med Sci. 2016;41(6):518.
85. Kim SY, Shin IG, Lee YM. Preparation and characterization of biodegradable nanospheres
composed of methoxy poly (ethylene glycol) and DL-lactide block copolymer as novel drug
carriers. J Control Release. 1998;56(1–3):197–208.
86. Sarmento B, Ribeiro A, Veiga F, Sampaio P, Neufeld R, Ferreira D. Alginate/chitosan
nanoparticles are effective for oral insulin delivery. Pharm Res. 2007;24(12):2198–206.
87. Ribeiro ME, Cavalcante IM, Ricardo NM, Mai SM, Attwood D, Yeates SG, et al. Solubilisation
of griseofulvin in aqueous micellar solutions of diblock copolymers of ethylene oxide
and 1,2-butylene oxide with lengthy B-blocks. Int J Pharm. 2009;369(1–2):196–8.. Epub
2008/12/02
88. Mei L, Zhang Z, Zhao L, Huang L, Yang X-L, Tang J, et al. Pharmaceutical nanotechnology
for oral delivery of anticancer drugs. Adv Drug Deliv Rev. 2013;65(6):880–90.
89. Ravichandran R. Nanoparticles in drug delivery: potential green nanobiomedicine applications. Int J Green Nanotechnol Biomed. 2009;1(2):B108–B30.
25 Role of Nanoparticles in the Management of Metabolic Disorders
70. Lecaroz MC, Blanco-Prieto MJ, Campanero MA, Salman H, Gamazo C. Poly (D, L-lactidecoglycolide) particles containing gentamicin: pharmacokinetics and pharmacodynamics in
Brucella melitensis-infected mice. Antimicrob Agents Chemother. 2007;51(4):1185–90.
71. Errico C, Bartoli C, Chiellini F, Chiellini E. Poly (hydroxyalkanoates)-based polymeric
nanoparticles for drug delivery. Biomed Res Int. 2009;2009:571702.
72. Park J, Fong PM, Lu J, Russell KS, Booth CJ, Saltzman WM, et al. PEGylated PLGA
nanoparticles for the improved delivery of doxorubicin. Nanomedicine. 2009;5(4):410–8.
73. Shah N, Chaudhari K, Dantuluri P, Murthy R, Das S. Paclitaxel-loaded PLGA nanoparticles
surface modified with transferrin and Pluronic® P85, an in vitro cell line and in vivo biodistribution studies on rat model. J Drug Target. 2009;17(7):533–42.
74. Yang H, Li K, Liu Y, Liu Z, Miyoshi H. Poly (D, L-lactide-co-glycolide) nanoparticles encapsulated fluorescent isothiocyanate and paclitaxol: preparation, release kinetics and anticancer
effect. J Nanosci Nanotechnol. 2009;9(1):282–7.
75. Kim T-H, Jeong Y-I, Jin S-G, Pei J, Jung T-Y, Moon K-S, et al. Preparation of polylactideco- glycolide nanoparticles incorporating celecoxib and their antitumor activity against brain
tumor cells. Int J Nanomedicine. 2011;6:2621–31.
76. Sundar S, Kundu J, Kundu SC. Biopolymeric nanoparticles. Sci Technol Adv Mater.
2010;11(1):014104.
77. de Assis DN, Mosqueira VCF, Vilela JMC, Andrade MS, Cardoso VN. Release profiles and
morphological characterization by atomic force microscopy and photon correlation spectroscopy of 99m technetium-fluconazole nanocapsules. Int J Pharm. 2008;349(1):152–60.
78. Shi HG, Farber L, Michaels JN, Dickey A, Thompson KC, Shelukar SD, et al. Characterization
of crystalline drug nanoparticles using atomic force microscopy and complementary techniques. Pharm Res. 2003;20(3):479–84.
79. Gupta H, Aqil M, Khar RK, Ali A, Bhatnagar A, Mittal G. Sparfloxacin-loaded PLGA
nanoparticles for sustained ocular drug delivery. Nanomedicine. 2010;6(2):324–33.
80. Zhao H, Lin ZY, Yildirimer L, Dhinakar A, Zhao X, Wu J. Polymer-based nanoparticles for
protein delivery: design, strategies and applications. J Mater Chem B. 2016;4(23):4060–71.
81. Naghsh N, Mashayekh AM, Khodadadi S. Effects of silver nanoparticle on lactate dehydrogenase activity and histological changes of heart tissue in male wistar rats. J Fasa Univ Med
Sci. 2013;2(4):303–7.
82. Razavian M, Safarpour E, Roshanai K, Yazdian M, Heidarieh N. Study of some biochemical
and hematological parameters changes of wistar rats blood parallel to oral nanosilver consumption. J Babol Univ Med Sci. 2011;13(1):22–7.
83. Alkaladi A, Abdelazim A, Afifi M. Antidiabetic activity of zinc oxide and silver nanoparticles
on streptozotocin-induced diabetic rats. Int J Mol Sci. 2014;15(2):2015–23.
84. Mousavi Z, Hassanpourezatti M, Najafizadeh P, Rezagholian S, Rhamanifar MS, Nosrati
N. Effects of subcutaneous injection MnO2 micro-and nanoparticles on blood glucose level
and lipid profile in rat. Iranian J Med Sci. 2016;41(6):518.
85. Kim SY, Shin IG, Lee YM. Preparation and characterization of biodegradable nanospheres
composed of methoxy poly (ethylene glycol) and DL-lactide block copolymer as novel drug
carriers. J Control Release. 1998;56(1–3):197–208.
86. Sarmento B, Ribeiro A, Veiga F, Sampaio P, Neufeld R, Ferreira D. Alginate/chitosan
nanoparticles are effective for oral insulin delivery. Pharm Res. 2007;24(12):2198–206.
87. Ribeiro ME, Cavalcante IM, Ricardo NM, Mai SM, Attwood D, Yeates SG, et al. Solubilisation
of griseofulvin in aqueous micellar solutions of diblock copolymers of ethylene oxide
and 1,2-butylene oxide with lengthy B-blocks. Int J Pharm. 2009;369(1–2):196–8.. Epub
2008/12/02
88. Mei L, Zhang Z, Zhao L, Huang L, Yang X-L, Tang J, et al. Pharmaceutical nanotechnology
for oral delivery of anticancer drugs. Adv Drug Deliv Rev. 2013;65(6):880–90.
89. Ravichandran R. Nanoparticles in drug delivery: potential green nanobiomedicine applications. Int J Green Nanotechnol Biomed. 2009;1(2):B108–B30.
25 Role of Nanoparticles in the Management of Metabolic Disorders